Sanofi

Sanofi is an R&D-driven, AI-powered biopharmaceutical company that develops medicines and vaccines across five core therapeutic areas: immunology, neurology, oncology, rare diseases and vaccines. The company employs more than 100,000 people and operates in upwards of 70 countries, spanning research laboratories, clinical development and field teams.

Its clinical development portfolio comprises 80 compounds, of which 28 are in Phase 3 trials. Sanofi applies artificial intelligence across the R&D value chain, supporting drug discovery, clinical development and vaccine development, with particular emphasis on immunology and the workings of the immune system. The breadth of this pipeline, together with a global operating footprint, places the company within a heavily regulated and multi-jurisdictional environment.

Sanofi describes its culture as one of collaboration and curiosity, with employees from varied backgrounds working across borders and disciplines. The company states a purpose of chasing scientific progress to improve people's lives, and reports commitments concerning patients, the planet and its own workforce.